Thank you, Chris. This morning, I will provide some additional details of our sales, fourth quarter and full year earnings and performance drivers, and our strong capital position. Starting with sales, as Chris mentioned at the beginning of the call, we generated $14,600,000,000 of gross sales for the full year, including $3,400,000,000 in the fourth quarter. We had $9,000,000,000 of gross sales of our core products, including indexed annuity, indexed universal life, and pension risk transfer. For the full year, this was our second year of more than $9,000,000,000 in core sales. This includes $2,800,000,000 of core sales in the quarter, in line with the 2024 and up 27% over the sequential third quarter. To provide a few highlights of our core sales, indexed annuities were $6,700,000,000 for the full year which was in line with full year 2024 and included $1,900,000,000 of indexed annuities in the quarter, up 12% over the 2024. This is a strong result in a competitive environment and coming off a record 2024 for fixed index annuities sales for both F&G Annuities & Life, Inc. and the industry. FIA is our largest contributor to indexed annuity sales and progressively increased during 2025, with modest but increasing Rilla sales throughout the year. IUL sales were a $190,000,000 for the full year, including over $50,000,000 in the quarter, and reflect a 14% increase over full year 2024. Our life insurance solutions are meeting the needs of the underserved, multi middle market which is driving continued steady growth. ERT sales were $2,100,000,000 for the full year, including over $800,000,000 in the quarter. This result marks our third consecutive year attaining $2,000,000,000 or more in PRT sales and landed squarely in our $1,500,000,000 to $2,500,000,000 targeted annual range. We continue to see a robust PRT pipeline for midsized deals up to 500,000,000 where F&G Annuities & Life, Inc. competes well. Gross sales of our opportunistic products including funding agreements and multiyear guaranteed annuities were $5,600,000,000 for the full year, including over $600,000,000 in the fourth quarter. Opportunistic sales volumes fluctuate quarter to quarter depending on economics and market opportunity. To provide a few highlights, funding agreements were $1,800,000,000 for the full year, up nearly 80% over the $1,000,000,000 in full year 2024. This included nearly $300,000,000 of funding agreements in the quarter, as compared to no funding agreements in the 2024. As we enter 2026, we took advantage of an attractive market window and successfully executed a $750,000,000 FABN issuance in early January as we continue to expand our high-quality investor base. MYGA sales were $3,800,000,000 for the full year, including over $350,000,000 in the quarter, as compared to $5,100,000,000 in 2024 including nearly $650,000,000 in the 2024. We have intentionally moderated MYGA volumes from the prior year level given market condition, competitive dynamics, and flow reinsurance optimization as we continue pricing discipline and allocating capital to the highest return opportunities throughout the year. F&G Annuities & Life, Inc.'s net sales retained were $10,000,000,000 for the full year 2025, as compared to $10,600,000,000 in full year 2024. This included $2,300,000,000 of net sales in the quarter, down slightly from the 2024. Stepping back, 2025 showcased the diversity of our new business engines, attractive liabilities allowing us to flex across our products and channels to source the most in a given environment. We are also uniquely positioned with our third-party MYGA flow reinsurance partners to dynamically adjust volumes up and down as the market economics change. This is not supplemented by a reinsurance sidecar and we expect our mix of sales to shift more toward FIA over time. As one of the industry's largest sellers of annuities and life insurance, our model is sustainable and allows us to optimize and position the business for long-term success. This aligns our interest well with the continued strong secular demand by consumers and financial advisers for retirement savings solutions, including our core indexed annuity and indexed life products.